Channing Capital Management LLC Acquires New Shares in The Cooper Companies, Inc. $COO

Key Points

• Channing Capital Management LLC acquired 110,683 shares of The Cooper Companies, Inc., valued at about $9.34 million, representing a stake of approximately 0.06% in the company.
• Cooper Companies reported earnings of $0.96 per share for the recent quarter, exceeding analyst estimates, and had a revenue of $1 billion, a 6.3% increase from the previous year.
• Analysts have a consensus rating of "Moderate Buy" for Cooper Companies, with a target price averaging $96.73, reflecting strong institutional interest in the stock.

Channing Capital Management LLC acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 110,683 shares of the medical device company's stock, valued at approximately $9,336,000. Channing Capital Management LLC owned about 0.06% of Cooper Companies at the end of the most recent quarter.

Several other large investors have also modified their holdings of COO. Zions Bancorporation National Association UT acquired a new position in shares of Cooper Companies in the 1st quarter valued at $33,000. City Holding Co. acquired a new position in Cooper Companies in the first quarter valued at $34,000. GKV Capital Management Co. Inc. purchased a new stake in shares of Cooper Companies in the first quarter valued at about $40,000. Larson Financial Group LLC boosted its stake in shares of Cooper Companies by 1,071.0% during the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after buying an additional 664 shares during the period. Finally, HM Payson & Co. grew its holdings in shares of Cooper Companies by 147.4% during the first quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after buying an additional 532 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Price Performance

COO stock traded up $2.18 on Friday, reaching $75.22. 1,992,159 shares of the company's stock were exchanged, compared to its average volume of 1,562,351. The stock has a fifty day moving average of $72.18 and a 200-day moving average of $78.20. The firm has a market cap of $15.04 billion, a PE ratio of 36.51, a P/E/G ratio of 1.84 and a beta of 1.00. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. During the same period in the previous year, the firm earned $0.85 EPS. The business's revenue was up 6.3% on a year-over-year basis. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have commented on COO. BNP Paribas raised Cooper Companies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 22nd. Robert W. Baird cut their price target on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research note on Friday, May 30th. Loop Capital set a $100.00 price objective on shares of Cooper Companies in a research report on Tuesday, June 17th. BNP Paribas Exane upgraded shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective for the company in a research report on Tuesday, July 22nd. Finally, Piper Sandler restated an "overweight" rating and issued a $105.00 target price (down previously from $115.00) on shares of Cooper Companies in a research note on Friday, May 30th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $96.73.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.